Tomoki Naoe
机构: Nagoya University, NHO Nagoya Medical Center
每年引用次数
引用次数
引用: 51,029
H-指数: 98
I10-指数 : 431
出版物: 881
Role of anti-oncomirs miR-143 and -145 in human colorectal tumors
Y Akao , Y Nakagawa , I Hirata , A Iio
Cancer Gene Therapy 17 ( 6) 398 -408
201
2010
Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation
M Yanada , , K Yamamoto , N Emi
Bone Marrow Transplantation 32 ( 8) 801 -807
45
2003
Allogeneic myeloablative transplantation for patients aged 50 years and over.
M Yanada , N Emi , T Naoe , H Sakamaki
Bone Marrow Transplantation 34 ( 1) 29 -35
28
2004
Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan
M Yanada , N Emi , T Naoe , H Sakamaki
Bone Marrow Transplantation 34 ( 4) 331 -337
54
2004
Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis
K Shimada , T Yokozawa , Y Atsuta , A Kohno
Bone Marrow Transplantation 36 ( 2) 115 -121
58
2005
Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease.
M Yanada , T Naoe , H Iida , H Sakamaki
Bone Marrow Transplantation 36 ( 10) 867 -872
44
2005
Increased risk for treatment-related mortality after bone marrow transplantation in GSTM1-positive recipients.
S Terakura , M Murata , T Nishida , N Emi
Bone Marrow Transplantation 37 ( 4) 381 -386
14
2006
Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation
Y Atsuta , R Suzuki , K Yamamoto , S Terakura
Bone Marrow Transplantation 37 ( 3) 289 -296
24
2006
Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation.
Y Inamoto , T Nishida , R Suzuki , K Miyamura
Bone Marrow Transplantation 39 ( 1) 25 -30
18
2007
Successful second cord blood transplantation using fludarabine and cyclophosphamide as a preparative regimen for graft rejection following reduced-intensity cord blood transplantation
E Mizutani , H Narimatsu , M Murata , A Tomita
Bone Marrow Transplantation 40 ( 1) 85 -87
11
2007
High incidence of secondary failure of platelet recovery after autologous and syngeneic peripheral blood stem cell transplantation in acute promyelocytic leukemia.
H Narimatsu , N Emi , A Kohno , M Iwai
Bone Marrow Transplantation 40 ( 8) 773 -778
5
2007
Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults.
K Sugimoto , , H Narimatsu , T Kawase
Bone Marrow Transplantation 41 ( 8) 729 -736
5
2008
Cytogenetic and cellular characteristics of a human embryonal rhabdomyosarcoma cell line, RMS-YM.
K Kubo , T Naoe , KR Utsumi , Y Ishiguro
British Journal of Cancer 63 ( 6) 879 -884
13
1991
A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Kohseisho Leukemia Study Group [see comments]
R Ohno , T Naoe , A Kanamaru , M Yoshida
Blood 83 ( 8) 2086 -2092
136
1994
Bernard-Soulier syndrome Kagoshima: Ser 444-->stop mutation of glycoprotein (GP) Ib alpha resulting in circulating truncated GPIb alpha and surface expression of GPIb beta and GPIX [see comments]
S Kunishima , H Miura , H Fukutani , H Yoshida
Blood 84 ( 10) 3356 -3362
54
1994
Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation
S Mizuta , , Y Ito , A Kohno
Bone Marrow Transplantation 24 ( 7) 777 -784
19
1999
Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCT
M Murata , T Nishida , S Taniguchi , K Ohashi
Bone Marrow Transplantation 49 ( 3) 355 -360
26
2014
The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis.
S Kako , S Morita , H Sakamaki , H Iida
Bone Marrow Transplantation 48 ( 8) 1077 -1083
3
2013
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis.
G N Mannis , A C Logan , A D Leavitt , M Yanada
Bone Marrow Transplantation 50 ( 1) 40 -44
9
2015
Cytotoxic T-lymphocyte antigen 4 haplotype correlates with relapse and survival after allogeneic hematopoietic SCT.
M Murase , T Nishida , M Onizuka , Y Inamoto
Bone Marrow Transplantation 46 ( 11) 1444 -1449
10
2011
Masamitsu Yanada Kazuyuki Shimada Keitaro Matsuo Yukio Kobayashi Miguel Sanz Hartmut Döhner francesco lo coco Clara D. Bloomfield, MD frederick appelbaum Yoshihiro Hatta Yukiya Yamamoto Hiroto Narimatsu Yukimasa Shiotsu Richard A. Larson Naoto Takahashi Wilson Miller Catriona Jamieson Pier Paolo Pandolfi